nodes	percent_of_prediction	percent_of_DWPC	metapath
Rivastigmine—Parkinson's disease—Memantine—Alzheimer's disease	0.316	1	CpDpCtD
Rivastigmine—ACHE—Alzheimer's disease	0.148	0.523	CbGaD
Rivastigmine—ACHE—Donepezil—Alzheimer's disease	0.115	0.413	CbGbCtD
Rivastigmine—BCHE—Alzheimer's disease	0.0873	0.308	CbGaD
Rivastigmine—ACHE—Galantamine—Alzheimer's disease	0.0741	0.266	CbGbCtD
Rivastigmine—CYP2D6—Alzheimer's disease	0.0479	0.169	CbGaD
Rivastigmine—BCHE—Galantamine—Alzheimer's disease	0.0446	0.16	CbGbCtD
Rivastigmine—CYP2D6—Donepezil—Alzheimer's disease	0.0166	0.0595	CbGbCtD
Rivastigmine—CYP2D6—Galantamine—Alzheimer's disease	0.0107	0.0384	CbGbCtD
Rivastigmine—CYP3A4—Donepezil—Alzheimer's disease	0.0105	0.0378	CbGbCtD
Rivastigmine—CYP3A4—Galantamine—Alzheimer's disease	0.00679	0.0244	CbGbCtD
Rivastigmine—Pyridostigmine—ACHE—Alzheimer's disease	0.000801	0.318	CrCbGaD
Rivastigmine—Neostigmine—ACHE—Alzheimer's disease	0.000607	0.241	CrCbGaD
Rivastigmine—Pyridostigmine—BCHE—Alzheimer's disease	0.000471	0.187	CrCbGaD
Rivastigmine—Neostigmine—BCHE—Alzheimer's disease	0.000357	0.142	CrCbGaD
Rivastigmine—Tapentadol—SLC6A4—Alzheimer's disease	0.000166	0.0658	CrCbGaD
Rivastigmine—Tapentadol—CYP2D6—Alzheimer's disease	0.000116	0.0463	CrCbGaD
Rivastigmine—Dysgeusia—Galantamine—Alzheimer's disease	7.87e-05	0.000799	CcSEcCtD
Rivastigmine—Acute coronary syndrome—Donepezil—Alzheimer's disease	7.86e-05	0.000797	CcSEcCtD
Rivastigmine—Renal failure—Donepezil—Alzheimer's disease	7.84e-05	0.000795	CcSEcCtD
Rivastigmine—Myocardial infarction—Donepezil—Alzheimer's disease	7.81e-05	0.000793	CcSEcCtD
Rivastigmine—Nervousness—Galantamine—Alzheimer's disease	7.81e-05	0.000792	CcSEcCtD
Rivastigmine—Bronchitis—Memantine—Alzheimer's disease	7.81e-05	0.000792	CcSEcCtD
Rivastigmine—Back pain—Galantamine—Alzheimer's disease	7.78e-05	0.000789	CcSEcCtD
Rivastigmine—Urinary tract infection—Donepezil—Alzheimer's disease	7.75e-05	0.000786	CcSEcCtD
Rivastigmine—Conjunctivitis—Donepezil—Alzheimer's disease	7.75e-05	0.000786	CcSEcCtD
Rivastigmine—Muscle spasms—Galantamine—Alzheimer's disease	7.73e-05	0.000784	CcSEcCtD
Rivastigmine—Sweating—Donepezil—Alzheimer's disease	7.64e-05	0.000775	CcSEcCtD
Rivastigmine—Haematuria—Donepezil—Alzheimer's disease	7.6e-05	0.000771	CcSEcCtD
Rivastigmine—Dysuria—Memantine—Alzheimer's disease	7.59e-05	0.00077	CcSEcCtD
Rivastigmine—Vision blurred—Galantamine—Alzheimer's disease	7.58e-05	0.000769	CcSEcCtD
Rivastigmine—Upper respiratory tract infection—Memantine—Alzheimer's disease	7.54e-05	0.000765	CcSEcCtD
Rivastigmine—Tremor—Galantamine—Alzheimer's disease	7.53e-05	0.000764	CcSEcCtD
Rivastigmine—Epistaxis—Donepezil—Alzheimer's disease	7.52e-05	0.000763	CcSEcCtD
Rivastigmine—Pollakiuria—Memantine—Alzheimer's disease	7.5e-05	0.000761	CcSEcCtD
Rivastigmine—Erectile dysfunction—Memantine—Alzheimer's disease	7.48e-05	0.000759	CcSEcCtD
Rivastigmine—Ill-defined disorder—Galantamine—Alzheimer's disease	7.46e-05	0.000757	CcSEcCtD
Rivastigmine—Anaemia—Galantamine—Alzheimer's disease	7.43e-05	0.000754	CcSEcCtD
Rivastigmine—Weight increased—Memantine—Alzheimer's disease	7.39e-05	0.00075	CcSEcCtD
Rivastigmine—Agitation—Galantamine—Alzheimer's disease	7.39e-05	0.000749	CcSEcCtD
Rivastigmine—Weight decreased—Memantine—Alzheimer's disease	7.34e-05	0.000745	CcSEcCtD
Rivastigmine—Hyperglycaemia—Memantine—Alzheimer's disease	7.32e-05	0.000743	CcSEcCtD
Rivastigmine—Bradycardia—Donepezil—Alzheimer's disease	7.29e-05	0.000739	CcSEcCtD
Rivastigmine—Pneumonia—Memantine—Alzheimer's disease	7.28e-05	0.000739	CcSEcCtD
Rivastigmine—Malaise—Galantamine—Alzheimer's disease	7.25e-05	0.000735	CcSEcCtD
Rivastigmine—Infestation—Memantine—Alzheimer's disease	7.24e-05	0.000734	CcSEcCtD
Rivastigmine—Infestation NOS—Memantine—Alzheimer's disease	7.24e-05	0.000734	CcSEcCtD
Rivastigmine—Vertigo—Galantamine—Alzheimer's disease	7.22e-05	0.000733	CcSEcCtD
Rivastigmine—Depression—Memantine—Alzheimer's disease	7.22e-05	0.000732	CcSEcCtD
Rivastigmine—Syncope—Galantamine—Alzheimer's disease	7.21e-05	0.000731	CcSEcCtD
Rivastigmine—Haemoglobin—Donepezil—Alzheimer's disease	7.19e-05	0.00073	CcSEcCtD
Rivastigmine—Stevens-Johnson syndrome—Memantine—Alzheimer's disease	7.18e-05	0.000728	CcSEcCtD
Rivastigmine—Rhinitis—Donepezil—Alzheimer's disease	7.17e-05	0.000728	CcSEcCtD
Rivastigmine—Haemorrhage—Donepezil—Alzheimer's disease	7.16e-05	0.000726	CcSEcCtD
Rivastigmine—Hepatitis—Donepezil—Alzheimer's disease	7.16e-05	0.000726	CcSEcCtD
Rivastigmine—Acute coronary syndrome—Memantine—Alzheimer's disease	7.14e-05	0.000724	CcSEcCtD
Rivastigmine—Hypoaesthesia—Donepezil—Alzheimer's disease	7.12e-05	0.000722	CcSEcCtD
Rivastigmine—Hallucination—Donepezil—Alzheimer's disease	7.12e-05	0.000722	CcSEcCtD
Rivastigmine—Renal failure—Memantine—Alzheimer's disease	7.11e-05	0.000722	CcSEcCtD
Rivastigmine—Palpitations—Galantamine—Alzheimer's disease	7.1e-05	0.000721	CcSEcCtD
Rivastigmine—Pharyngitis—Donepezil—Alzheimer's disease	7.1e-05	0.000721	CcSEcCtD
Rivastigmine—Neuropathy peripheral—Memantine—Alzheimer's disease	7.09e-05	0.00072	CcSEcCtD
Rivastigmine—Myocardial infarction—Memantine—Alzheimer's disease	7.09e-05	0.00072	CcSEcCtD
Rivastigmine—Urinary tract disorder—Donepezil—Alzheimer's disease	7.07e-05	0.000717	CcSEcCtD
Rivastigmine—Loss of consciousness—Galantamine—Alzheimer's disease	7.06e-05	0.000717	CcSEcCtD
Rivastigmine—Oedema peripheral—Donepezil—Alzheimer's disease	7.05e-05	0.000715	CcSEcCtD
Rivastigmine—Urinary tract infection—Memantine—Alzheimer's disease	7.04e-05	0.000714	CcSEcCtD
Rivastigmine—Conjunctivitis—Memantine—Alzheimer's disease	7.04e-05	0.000714	CcSEcCtD
Rivastigmine—Urethral disorder—Donepezil—Alzheimer's disease	7.01e-05	0.000712	CcSEcCtD
Rivastigmine—Cough—Galantamine—Alzheimer's disease	7.01e-05	0.000712	CcSEcCtD
Rivastigmine—Convulsion—Galantamine—Alzheimer's disease	6.96e-05	0.000707	CcSEcCtD
Rivastigmine—Hypertension—Galantamine—Alzheimer's disease	6.94e-05	0.000704	CcSEcCtD
Rivastigmine—Haematuria—Memantine—Alzheimer's disease	6.9e-05	0.0007	CcSEcCtD
Rivastigmine—Visual impairment—Donepezil—Alzheimer's disease	6.9e-05	0.0007	CcSEcCtD
Rivastigmine—Hepatobiliary disease—Memantine—Alzheimer's disease	6.85e-05	0.000694	CcSEcCtD
Rivastigmine—Arthralgia—Galantamine—Alzheimer's disease	6.84e-05	0.000694	CcSEcCtD
Rivastigmine—Chest pain—Galantamine—Alzheimer's disease	6.84e-05	0.000694	CcSEcCtD
Rivastigmine—Myalgia—Galantamine—Alzheimer's disease	6.84e-05	0.000694	CcSEcCtD
Rivastigmine—Epistaxis—Memantine—Alzheimer's disease	6.83e-05	0.000693	CcSEcCtD
Rivastigmine—Anxiety—Galantamine—Alzheimer's disease	6.82e-05	0.000692	CcSEcCtD
Rivastigmine—Unspecified disorder of skin and subcutaneous tissue—Galantamine—Alzheimer's disease	6.8e-05	0.00069	CcSEcCtD
Rivastigmine—Sinusitis—Memantine—Alzheimer's disease	6.79e-05	0.000689	CcSEcCtD
Rivastigmine—Discomfort—Galantamine—Alzheimer's disease	6.76e-05	0.000686	CcSEcCtD
Rivastigmine—Dry mouth—Galantamine—Alzheimer's disease	6.69e-05	0.000679	CcSEcCtD
Rivastigmine—Tinnitus—Donepezil—Alzheimer's disease	6.67e-05	0.000677	CcSEcCtD
Rivastigmine—Confusional state—Galantamine—Alzheimer's disease	6.61e-05	0.000671	CcSEcCtD
Rivastigmine—Bradycardia—Memantine—Alzheimer's disease	6.61e-05	0.000671	CcSEcCtD
Rivastigmine—Haemoglobin—Memantine—Alzheimer's disease	6.53e-05	0.000663	CcSEcCtD
Rivastigmine—Rhinitis—Memantine—Alzheimer's disease	6.51e-05	0.000661	CcSEcCtD
Rivastigmine—Haemorrhage—Memantine—Alzheimer's disease	6.5e-05	0.000659	CcSEcCtD
Rivastigmine—Hepatitis—Memantine—Alzheimer's disease	6.5e-05	0.000659	CcSEcCtD
Rivastigmine—Hypoaesthesia—Memantine—Alzheimer's disease	6.46e-05	0.000656	CcSEcCtD
Rivastigmine—Hallucination—Memantine—Alzheimer's disease	6.46e-05	0.000656	CcSEcCtD
Rivastigmine—Shock—Galantamine—Alzheimer's disease	6.45e-05	0.000655	CcSEcCtD
Rivastigmine—Pharyngitis—Memantine—Alzheimer's disease	6.45e-05	0.000654	CcSEcCtD
Rivastigmine—Nervous system disorder—Galantamine—Alzheimer's disease	6.43e-05	0.000653	CcSEcCtD
Rivastigmine—Thrombocytopenia—Galantamine—Alzheimer's disease	6.42e-05	0.000652	CcSEcCtD
Rivastigmine—Chills—Donepezil—Alzheimer's disease	6.42e-05	0.000651	CcSEcCtD
Rivastigmine—Urinary tract disorder—Memantine—Alzheimer's disease	6.42e-05	0.000651	CcSEcCtD
Rivastigmine—Tachycardia—Galantamine—Alzheimer's disease	6.4e-05	0.00065	CcSEcCtD
Rivastigmine—Oedema peripheral—Memantine—Alzheimer's disease	6.4e-05	0.000649	CcSEcCtD
Rivastigmine—Arrhythmia—Donepezil—Alzheimer's disease	6.39e-05	0.000649	CcSEcCtD
Rivastigmine—Connective tissue disorder—Memantine—Alzheimer's disease	6.38e-05	0.000648	CcSEcCtD
Rivastigmine—Skin disorder—Galantamine—Alzheimer's disease	6.37e-05	0.000646	CcSEcCtD
Rivastigmine—Urethral disorder—Memantine—Alzheimer's disease	6.37e-05	0.000646	CcSEcCtD
Rivastigmine—Hyperhidrosis—Galantamine—Alzheimer's disease	6.34e-05	0.000643	CcSEcCtD
Rivastigmine—Alopecia—Donepezil—Alzheimer's disease	6.32e-05	0.000642	CcSEcCtD
Rivastigmine—Mental disorder—Donepezil—Alzheimer's disease	6.27e-05	0.000636	CcSEcCtD
Rivastigmine—Visual impairment—Memantine—Alzheimer's disease	6.26e-05	0.000635	CcSEcCtD
Rivastigmine—Anorexia—Galantamine—Alzheimer's disease	6.25e-05	0.000634	CcSEcCtD
Rivastigmine—Malnutrition—Donepezil—Alzheimer's disease	6.23e-05	0.000632	CcSEcCtD
Rivastigmine—Erythema—Donepezil—Alzheimer's disease	6.23e-05	0.000632	CcSEcCtD
Rivastigmine—Erythema multiforme—Memantine—Alzheimer's disease	6.14e-05	0.000623	CcSEcCtD
Rivastigmine—Flatulence—Donepezil—Alzheimer's disease	6.14e-05	0.000623	CcSEcCtD
Rivastigmine—Hypotension—Galantamine—Alzheimer's disease	6.13e-05	0.000622	CcSEcCtD
Rivastigmine—Tension—Donepezil—Alzheimer's disease	6.11e-05	0.00062	CcSEcCtD
Rivastigmine—Dysgeusia—Donepezil—Alzheimer's disease	6.1e-05	0.000619	CcSEcCtD
Rivastigmine—Eye disorder—Memantine—Alzheimer's disease	6.07e-05	0.000616	CcSEcCtD
Rivastigmine—Tinnitus—Memantine—Alzheimer's disease	6.06e-05	0.000615	CcSEcCtD
Rivastigmine—Nervousness—Donepezil—Alzheimer's disease	6.05e-05	0.000614	CcSEcCtD
Rivastigmine—Flushing—Memantine—Alzheimer's disease	6.03e-05	0.000612	CcSEcCtD
Rivastigmine—Cardiac disorder—Memantine—Alzheimer's disease	6.03e-05	0.000612	CcSEcCtD
Rivastigmine—Back pain—Donepezil—Alzheimer's disease	6.03e-05	0.000611	CcSEcCtD
Rivastigmine—Muscle spasms—Donepezil—Alzheimer's disease	5.99e-05	0.000608	CcSEcCtD
Rivastigmine—Musculoskeletal discomfort—Galantamine—Alzheimer's disease	5.98e-05	0.000606	CcSEcCtD
Rivastigmine—Insomnia—Galantamine—Alzheimer's disease	5.93e-05	0.000602	CcSEcCtD
Rivastigmine—Angiopathy—Memantine—Alzheimer's disease	5.9e-05	0.000598	CcSEcCtD
Rivastigmine—Paraesthesia—Galantamine—Alzheimer's disease	5.89e-05	0.000598	CcSEcCtD
Rivastigmine—Vision blurred—Donepezil—Alzheimer's disease	5.87e-05	0.000596	CcSEcCtD
Rivastigmine—Mediastinal disorder—Memantine—Alzheimer's disease	5.86e-05	0.000594	CcSEcCtD
Rivastigmine—Tremor—Donepezil—Alzheimer's disease	5.84e-05	0.000592	CcSEcCtD
Rivastigmine—Somnolence—Galantamine—Alzheimer's disease	5.83e-05	0.000592	CcSEcCtD
Rivastigmine—Chills—Memantine—Alzheimer's disease	5.83e-05	0.000591	CcSEcCtD
Rivastigmine—Arrhythmia—Memantine—Alzheimer's disease	5.8e-05	0.000589	CcSEcCtD
Rivastigmine—Ill-defined disorder—Donepezil—Alzheimer's disease	5.78e-05	0.000586	CcSEcCtD
Rivastigmine—Dyspepsia—Galantamine—Alzheimer's disease	5.77e-05	0.000586	CcSEcCtD
Rivastigmine—Anaemia—Donepezil—Alzheimer's disease	5.76e-05	0.000584	CcSEcCtD
Rivastigmine—Alopecia—Memantine—Alzheimer's disease	5.74e-05	0.000583	CcSEcCtD
Rivastigmine—Agitation—Donepezil—Alzheimer's disease	5.72e-05	0.000581	CcSEcCtD
Rivastigmine—Decreased appetite—Galantamine—Alzheimer's disease	5.7e-05	0.000579	CcSEcCtD
Rivastigmine—Mental disorder—Memantine—Alzheimer's disease	5.69e-05	0.000578	CcSEcCtD
Rivastigmine—Gastrointestinal disorder—Galantamine—Alzheimer's disease	5.66e-05	0.000575	CcSEcCtD
Rivastigmine—Malnutrition—Memantine—Alzheimer's disease	5.66e-05	0.000574	CcSEcCtD
Rivastigmine—Fatigue—Galantamine—Alzheimer's disease	5.66e-05	0.000574	CcSEcCtD
Rivastigmine—Malaise—Donepezil—Alzheimer's disease	5.62e-05	0.00057	CcSEcCtD
Rivastigmine—Constipation—Galantamine—Alzheimer's disease	5.61e-05	0.000569	CcSEcCtD
Rivastigmine—Vertigo—Donepezil—Alzheimer's disease	5.6e-05	0.000568	CcSEcCtD
Rivastigmine—Syncope—Donepezil—Alzheimer's disease	5.59e-05	0.000567	CcSEcCtD
Rivastigmine—Flatulence—Memantine—Alzheimer's disease	5.57e-05	0.000565	CcSEcCtD
Rivastigmine—Tension—Memantine—Alzheimer's disease	5.55e-05	0.000563	CcSEcCtD
Rivastigmine—Dysgeusia—Memantine—Alzheimer's disease	5.54e-05	0.000562	CcSEcCtD
Rivastigmine—Nervousness—Memantine—Alzheimer's disease	5.49e-05	0.000557	CcSEcCtD
Rivastigmine—Loss of consciousness—Donepezil—Alzheimer's disease	5.48e-05	0.000555	CcSEcCtD
Rivastigmine—Back pain—Memantine—Alzheimer's disease	5.47e-05	0.000555	CcSEcCtD
Rivastigmine—Cough—Donepezil—Alzheimer's disease	5.44e-05	0.000552	CcSEcCtD
Rivastigmine—Feeling abnormal—Galantamine—Alzheimer's disease	5.41e-05	0.000548	CcSEcCtD
Rivastigmine—Convulsion—Donepezil—Alzheimer's disease	5.4e-05	0.000548	CcSEcCtD
Rivastigmine—Hypertension—Donepezil—Alzheimer's disease	5.38e-05	0.000546	CcSEcCtD
Rivastigmine—Gastrointestinal pain—Galantamine—Alzheimer's disease	5.36e-05	0.000544	CcSEcCtD
Rivastigmine—Vision blurred—Memantine—Alzheimer's disease	5.33e-05	0.000541	CcSEcCtD
Rivastigmine—Myalgia—Donepezil—Alzheimer's disease	5.3e-05	0.000538	CcSEcCtD
Rivastigmine—Chest pain—Donepezil—Alzheimer's disease	5.3e-05	0.000538	CcSEcCtD
Rivastigmine—Arthralgia—Donepezil—Alzheimer's disease	5.3e-05	0.000538	CcSEcCtD
Rivastigmine—Tremor—Memantine—Alzheimer's disease	5.3e-05	0.000538	CcSEcCtD
Rivastigmine—Anxiety—Donepezil—Alzheimer's disease	5.29e-05	0.000536	CcSEcCtD
Rivastigmine—Ill-defined disorder—Memantine—Alzheimer's disease	5.25e-05	0.000532	CcSEcCtD
Rivastigmine—Discomfort—Donepezil—Alzheimer's disease	5.24e-05	0.000532	CcSEcCtD
Rivastigmine—Anaemia—Memantine—Alzheimer's disease	5.23e-05	0.00053	CcSEcCtD
Rivastigmine—Agitation—Memantine—Alzheimer's disease	5.2e-05	0.000527	CcSEcCtD
Rivastigmine—Dry mouth—Donepezil—Alzheimer's disease	5.19e-05	0.000526	CcSEcCtD
Rivastigmine—Abdominal pain—Galantamine—Alzheimer's disease	5.19e-05	0.000526	CcSEcCtD
Rivastigmine—Body temperature increased—Galantamine—Alzheimer's disease	5.19e-05	0.000526	CcSEcCtD
Rivastigmine—Confusional state—Donepezil—Alzheimer's disease	5.13e-05	0.00052	CcSEcCtD
Rivastigmine—Malaise—Memantine—Alzheimer's disease	5.1e-05	0.000517	CcSEcCtD
Rivastigmine—Oedema—Donepezil—Alzheimer's disease	5.08e-05	0.000516	CcSEcCtD
Rivastigmine—Vertigo—Memantine—Alzheimer's disease	5.08e-05	0.000516	CcSEcCtD
Rivastigmine—Syncope—Memantine—Alzheimer's disease	5.07e-05	0.000515	CcSEcCtD
Rivastigmine—Infection—Donepezil—Alzheimer's disease	5.05e-05	0.000512	CcSEcCtD
Rivastigmine—Shock—Donepezil—Alzheimer's disease	5e-05	0.000507	CcSEcCtD
Rivastigmine—Palpitations—Memantine—Alzheimer's disease	5e-05	0.000507	CcSEcCtD
Rivastigmine—Nervous system disorder—Donepezil—Alzheimer's disease	4.99e-05	0.000506	CcSEcCtD
Rivastigmine—Thrombocytopenia—Donepezil—Alzheimer's disease	4.98e-05	0.000505	CcSEcCtD
Rivastigmine—Loss of consciousness—Memantine—Alzheimer's disease	4.97e-05	0.000504	CcSEcCtD
Rivastigmine—Cough—Memantine—Alzheimer's disease	4.94e-05	0.000501	CcSEcCtD
Rivastigmine—Hyperhidrosis—Donepezil—Alzheimer's disease	4.91e-05	0.000499	CcSEcCtD
Rivastigmine—Convulsion—Memantine—Alzheimer's disease	4.9e-05	0.000497	CcSEcCtD
Rivastigmine—Hypertension—Memantine—Alzheimer's disease	4.88e-05	0.000495	CcSEcCtD
Rivastigmine—Anorexia—Donepezil—Alzheimer's disease	4.85e-05	0.000492	CcSEcCtD
Rivastigmine—Hypersensitivity—Galantamine—Alzheimer's disease	4.83e-05	0.00049	CcSEcCtD
Rivastigmine—Arthralgia—Memantine—Alzheimer's disease	4.82e-05	0.000489	CcSEcCtD
Rivastigmine—Myalgia—Memantine—Alzheimer's disease	4.82e-05	0.000489	CcSEcCtD
Rivastigmine—Chest pain—Memantine—Alzheimer's disease	4.82e-05	0.000489	CcSEcCtD
Rivastigmine—Anxiety—Memantine—Alzheimer's disease	4.8e-05	0.000487	CcSEcCtD
Rivastigmine—Discomfort—Memantine—Alzheimer's disease	4.76e-05	0.000483	CcSEcCtD
Rivastigmine—Hypotension—Donepezil—Alzheimer's disease	4.75e-05	0.000482	CcSEcCtD
Rivastigmine—Dry mouth—Memantine—Alzheimer's disease	4.71e-05	0.000478	CcSEcCtD
Rivastigmine—Asthenia—Galantamine—Alzheimer's disease	4.71e-05	0.000478	CcSEcCtD
Rivastigmine—BCHE—Metabolism of proteins—ADAMTS2—Alzheimer's disease	4.69e-05	0.0022	CbGpPWpGaD
Rivastigmine—Confusional state—Memantine—Alzheimer's disease	4.65e-05	0.000472	CcSEcCtD
Rivastigmine—ACHE—Transmission across Chemical Synapses—PLCB1—Alzheimer's disease	4.65e-05	0.00218	CbGpPWpGaD
Rivastigmine—Musculoskeletal discomfort—Donepezil—Alzheimer's disease	4.63e-05	0.00047	CcSEcCtD
Rivastigmine—Oedema—Memantine—Alzheimer's disease	4.62e-05	0.000468	CcSEcCtD
Rivastigmine—CYP2D6—Phase 1 - Functionalization of compounds—PTGS1—Alzheimer's disease	4.61e-05	0.00216	CbGpPWpGaD
Rivastigmine—ACHE—ATF-2 transcription factor network—MAPK8—Alzheimer's disease	4.6e-05	0.00216	CbGpPWpGaD
Rivastigmine—Insomnia—Donepezil—Alzheimer's disease	4.6e-05	0.000467	CcSEcCtD
Rivastigmine—Infection—Memantine—Alzheimer's disease	4.59e-05	0.000465	CcSEcCtD
Rivastigmine—Paraesthesia—Donepezil—Alzheimer's disease	4.57e-05	0.000463	CcSEcCtD
Rivastigmine—ACHE—Metabolism of proteins—SLC30A6—Alzheimer's disease	4.56e-05	0.00214	CbGpPWpGaD
Rivastigmine—Shock—Memantine—Alzheimer's disease	4.54e-05	0.000461	CcSEcCtD
Rivastigmine—Dyspnoea—Donepezil—Alzheimer's disease	4.53e-05	0.00046	CcSEcCtD
Rivastigmine—BCHE—Metabolism of lipids and lipoproteins—CYP46A1—Alzheimer's disease	4.53e-05	0.00212	CbGpPWpGaD
Rivastigmine—Nervous system disorder—Memantine—Alzheimer's disease	4.53e-05	0.000459	CcSEcCtD
Rivastigmine—Somnolence—Donepezil—Alzheimer's disease	4.52e-05	0.000459	CcSEcCtD
Rivastigmine—Thrombocytopenia—Memantine—Alzheimer's disease	4.52e-05	0.000459	CcSEcCtD
Rivastigmine—CYP3A4—Constitutive Androstane Receptor Pathway—PPARGC1A—Alzheimer's disease	4.51e-05	0.00211	CbGpPWpGaD
Rivastigmine—Tachycardia—Memantine—Alzheimer's disease	4.51e-05	0.000457	CcSEcCtD
Rivastigmine—Diarrhoea—Galantamine—Alzheimer's disease	4.49e-05	0.000455	CcSEcCtD
Rivastigmine—Skin disorder—Memantine—Alzheimer's disease	4.48e-05	0.000455	CcSEcCtD
Rivastigmine—BCHE—Peptide hormone metabolism—INS—Alzheimer's disease	4.48e-05	0.0021	CbGpPWpGaD
Rivastigmine—Dyspepsia—Donepezil—Alzheimer's disease	4.48e-05	0.000454	CcSEcCtD
Rivastigmine—Hyperhidrosis—Memantine—Alzheimer's disease	4.46e-05	0.000453	CcSEcCtD
Rivastigmine—BCHE—Metabolism of proteins—ATP5A1—Alzheimer's disease	4.44e-05	0.00208	CbGpPWpGaD
Rivastigmine—BCHE—Neuronal System—GRIA1—Alzheimer's disease	4.44e-05	0.00208	CbGpPWpGaD
Rivastigmine—Decreased appetite—Donepezil—Alzheimer's disease	4.42e-05	0.000448	CcSEcCtD
Rivastigmine—Anorexia—Memantine—Alzheimer's disease	4.4e-05	0.000446	CcSEcCtD
Rivastigmine—Gastrointestinal disorder—Donepezil—Alzheimer's disease	4.39e-05	0.000445	CcSEcCtD
Rivastigmine—Fatigue—Donepezil—Alzheimer's disease	4.38e-05	0.000445	CcSEcCtD
Rivastigmine—Constipation—Donepezil—Alzheimer's disease	4.35e-05	0.000441	CcSEcCtD
Rivastigmine—Pain—Donepezil—Alzheimer's disease	4.35e-05	0.000441	CcSEcCtD
Rivastigmine—Dizziness—Galantamine—Alzheimer's disease	4.34e-05	0.00044	CcSEcCtD
Rivastigmine—BCHE—Peptide hormone metabolism—IGF1—Alzheimer's disease	4.33e-05	0.00203	CbGpPWpGaD
Rivastigmine—Hypotension—Memantine—Alzheimer's disease	4.31e-05	0.000438	CcSEcCtD
Rivastigmine—BCHE—Transmission across Chemical Synapses—DLG4—Alzheimer's disease	4.29e-05	0.00201	CbGpPWpGaD
Rivastigmine—ACHE—Neuronal System—CHRNA4—Alzheimer's disease	4.28e-05	0.00201	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of proteins—TPP1—Alzheimer's disease	4.24e-05	0.00199	CbGpPWpGaD
Rivastigmine—BCHE—Neuronal System—CHRNB2—Alzheimer's disease	4.21e-05	0.00197	CbGpPWpGaD
Rivastigmine—Musculoskeletal discomfort—Memantine—Alzheimer's disease	4.21e-05	0.000427	CcSEcCtD
Rivastigmine—BCHE—Transmission across Chemical Synapses—GRIN2B—Alzheimer's disease	4.19e-05	0.00196	CbGpPWpGaD
Rivastigmine—Feeling abnormal—Donepezil—Alzheimer's disease	4.19e-05	0.000425	CcSEcCtD
Rivastigmine—Insomnia—Memantine—Alzheimer's disease	4.18e-05	0.000424	CcSEcCtD
Rivastigmine—Vomiting—Galantamine—Alzheimer's disease	4.17e-05	0.000423	CcSEcCtD
Rivastigmine—Gastrointestinal pain—Donepezil—Alzheimer's disease	4.16e-05	0.000422	CcSEcCtD
Rivastigmine—BCHE—Transmission across Chemical Synapses—PLCB1—Alzheimer's disease	4.15e-05	0.00194	CbGpPWpGaD
Rivastigmine—Paraesthesia—Memantine—Alzheimer's disease	4.15e-05	0.000421	CcSEcCtD
Rivastigmine—Rash—Galantamine—Alzheimer's disease	4.14e-05	0.00042	CcSEcCtD
Rivastigmine—Dermatitis—Galantamine—Alzheimer's disease	4.13e-05	0.000419	CcSEcCtD
Rivastigmine—Dyspnoea—Memantine—Alzheimer's disease	4.12e-05	0.000418	CcSEcCtD
Rivastigmine—Headache—Galantamine—Alzheimer's disease	4.11e-05	0.000417	CcSEcCtD
Rivastigmine—Somnolence—Memantine—Alzheimer's disease	4.1e-05	0.000416	CcSEcCtD
Rivastigmine—BCHE—Metabolism of proteins—SLC30A6—Alzheimer's disease	4.06e-05	0.0019	CbGpPWpGaD
Rivastigmine—Dyspepsia—Memantine—Alzheimer's disease	4.06e-05	0.000412	CcSEcCtD
Rivastigmine—Urticaria—Donepezil—Alzheimer's disease	4.04e-05	0.00041	CcSEcCtD
Rivastigmine—Abdominal pain—Donepezil—Alzheimer's disease	4.02e-05	0.000408	CcSEcCtD
Rivastigmine—Body temperature increased—Donepezil—Alzheimer's disease	4.02e-05	0.000408	CcSEcCtD
Rivastigmine—Decreased appetite—Memantine—Alzheimer's disease	4.01e-05	0.000407	CcSEcCtD
Rivastigmine—Gastrointestinal disorder—Memantine—Alzheimer's disease	3.99e-05	0.000404	CcSEcCtD
Rivastigmine—CYP3A4—Phase 1 - Functionalization of compounds—MAOB—Alzheimer's disease	3.98e-05	0.00187	CbGpPWpGaD
Rivastigmine—Fatigue—Memantine—Alzheimer's disease	3.98e-05	0.000404	CcSEcCtD
Rivastigmine—Constipation—Memantine—Alzheimer's disease	3.95e-05	0.0004	CcSEcCtD
Rivastigmine—Pain—Memantine—Alzheimer's disease	3.95e-05	0.0004	CcSEcCtD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—BDNF—Alzheimer's disease	3.91e-05	0.00183	CbGpPWpGaD
Rivastigmine—Nausea—Galantamine—Alzheimer's disease	3.9e-05	0.000395	CcSEcCtD
Rivastigmine—BCHE—Neuronal System—ACHE—Alzheimer's disease	3.86e-05	0.00181	CbGpPWpGaD
Rivastigmine—BCHE—Neuronal System—CHRNA4—Alzheimer's disease	3.82e-05	0.00179	CbGpPWpGaD
Rivastigmine—Feeling abnormal—Memantine—Alzheimer's disease	3.8e-05	0.000386	CcSEcCtD
Rivastigmine—BCHE—Metabolism of proteins—TPP1—Alzheimer's disease	3.78e-05	0.00177	CbGpPWpGaD
Rivastigmine—Gastrointestinal pain—Memantine—Alzheimer's disease	3.77e-05	0.000383	CcSEcCtD
Rivastigmine—ACHE—Neuronal System—BCHE—Alzheimer's disease	3.77e-05	0.00177	CbGpPWpGaD
Rivastigmine—Hypersensitivity—Donepezil—Alzheimer's disease	3.75e-05	0.00038	CcSEcCtD
Rivastigmine—ACHE—Neuronal System—DLG4—Alzheimer's disease	3.68e-05	0.00173	CbGpPWpGaD
Rivastigmine—Urticaria—Memantine—Alzheimer's disease	3.67e-05	0.000372	CcSEcCtD
Rivastigmine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2D6—Alzheimer's disease	3.65e-05	0.00171	CbGpPWpGaD
Rivastigmine—Abdominal pain—Memantine—Alzheimer's disease	3.65e-05	0.00037	CcSEcCtD
Rivastigmine—Body temperature increased—Memantine—Alzheimer's disease	3.65e-05	0.00037	CcSEcCtD
Rivastigmine—Asthenia—Donepezil—Alzheimer's disease	3.65e-05	0.00037	CcSEcCtD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—BAX—Alzheimer's disease	3.64e-05	0.00171	CbGpPWpGaD
Rivastigmine—CYP3A4—Oxidation by Cytochrome P450—CYP2D6—Alzheimer's disease	3.6e-05	0.00169	CbGpPWpGaD
Rivastigmine—ACHE—Neuronal System—GRIN2B—Alzheimer's disease	3.6e-05	0.00169	CbGpPWpGaD
Rivastigmine—Pruritus—Donepezil—Alzheimer's disease	3.6e-05	0.000365	CcSEcCtD
Rivastigmine—ACHE—Neuronal System—PLCB1—Alzheimer's disease	3.56e-05	0.00167	CbGpPWpGaD
Rivastigmine—CYP3A4—Biological oxidations—CYP46A1—Alzheimer's disease	3.54e-05	0.00166	CbGpPWpGaD
Rivastigmine—CYP3A4—Metapathway biotransformation—CYP46A1—Alzheimer's disease	3.5e-05	0.00164	CbGpPWpGaD
Rivastigmine—Diarrhoea—Donepezil—Alzheimer's disease	3.48e-05	0.000353	CcSEcCtD
Rivastigmine—ACHE—Transmission across Chemical Synapses—PRKCG—Alzheimer's disease	3.44e-05	0.00161	CbGpPWpGaD
Rivastigmine—Hypersensitivity—Memantine—Alzheimer's disease	3.4e-05	0.000345	CcSEcCtD
Rivastigmine—ACHE—Metabolism—DHCR24—Alzheimer's disease	3.39e-05	0.00159	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of proteins—ADAMTS4—Alzheimer's disease	3.39e-05	0.00159	CbGpPWpGaD
Rivastigmine—Dizziness—Donepezil—Alzheimer's disease	3.36e-05	0.000341	CcSEcCtD
Rivastigmine—Asthenia—Memantine—Alzheimer's disease	3.31e-05	0.000336	CcSEcCtD
Rivastigmine—BCHE—Neuronal System—DLG4—Alzheimer's disease	3.29e-05	0.00154	CbGpPWpGaD
Rivastigmine—Pruritus—Memantine—Alzheimer's disease	3.27e-05	0.000331	CcSEcCtD
Rivastigmine—CYP2D6—Biological oxidations—MAOB—Alzheimer's disease	3.23e-05	0.00152	CbGpPWpGaD
Rivastigmine—Vomiting—Donepezil—Alzheimer's disease	3.23e-05	0.000328	CcSEcCtD
Rivastigmine—BCHE—Neuronal System—GRIN2B—Alzheimer's disease	3.21e-05	0.00151	CbGpPWpGaD
Rivastigmine—Rash—Donepezil—Alzheimer's disease	3.21e-05	0.000325	CcSEcCtD
Rivastigmine—Dermatitis—Donepezil—Alzheimer's disease	3.2e-05	0.000325	CcSEcCtD
Rivastigmine—Headache—Donepezil—Alzheimer's disease	3.19e-05	0.000323	CcSEcCtD
Rivastigmine—BCHE—Neuronal System—PLCB1—Alzheimer's disease	3.18e-05	0.00149	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of lipids and lipoproteins—CHAT—Alzheimer's disease	3.16e-05	0.00148	CbGpPWpGaD
Rivastigmine—Diarrhoea—Memantine—Alzheimer's disease	3.16e-05	0.00032	CcSEcCtD
Rivastigmine—BCHE—Transmission across Chemical Synapses—PRKCG—Alzheimer's disease	3.07e-05	0.00144	CbGpPWpGaD
Rivastigmine—Dizziness—Memantine—Alzheimer's disease	3.05e-05	0.00031	CcSEcCtD
Rivastigmine—BCHE—Metabolism—DHCR24—Alzheimer's disease	3.02e-05	0.00142	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of proteins—ADAMTS4—Alzheimer's disease	3.02e-05	0.00142	CbGpPWpGaD
Rivastigmine—Nausea—Donepezil—Alzheimer's disease	3.02e-05	0.000306	CcSEcCtD
Rivastigmine—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—Alzheimer's disease	3.02e-05	0.00141	CbGpPWpGaD
Rivastigmine—ACHE—Transmission across Chemical Synapses—CALM1—Alzheimer's disease	2.97e-05	0.00139	CbGpPWpGaD
Rivastigmine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2D6—Alzheimer's disease	2.96e-05	0.00139	CbGpPWpGaD
Rivastigmine—ACHE—ATF-2 transcription factor network—IL6—Alzheimer's disease	2.94e-05	0.00138	CbGpPWpGaD
Rivastigmine—Vomiting—Memantine—Alzheimer's disease	2.94e-05	0.000298	CcSEcCtD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—ESR1—Alzheimer's disease	2.93e-05	0.00138	CbGpPWpGaD
Rivastigmine—Rash—Memantine—Alzheimer's disease	2.91e-05	0.000295	CcSEcCtD
Rivastigmine—Dermatitis—Memantine—Alzheimer's disease	2.91e-05	0.000295	CcSEcCtD
Rivastigmine—Headache—Memantine—Alzheimer's disease	2.89e-05	0.000293	CcSEcCtD
Rivastigmine—ACHE—Metabolism—CA4—Alzheimer's disease	2.88e-05	0.00135	CbGpPWpGaD
Rivastigmine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Alzheimer's disease	2.86e-05	0.00134	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of lipids and lipoproteins—CHAT—Alzheimer's disease	2.82e-05	0.00132	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of lipids and lipoproteins—A2M—Alzheimer's disease	2.82e-05	0.00132	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of proteins—MME—Alzheimer's disease	2.76e-05	0.00129	CbGpPWpGaD
Rivastigmine—Nausea—Memantine—Alzheimer's disease	2.74e-05	0.000278	CcSEcCtD
Rivastigmine—ACHE—Metabolism—GAPDHS—Alzheimer's disease	2.71e-05	0.00127	CbGpPWpGaD
Rivastigmine—BCHE—Transmission across Chemical Synapses—CALM1—Alzheimer's disease	2.65e-05	0.00124	CbGpPWpGaD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—CREB1—Alzheimer's disease	2.64e-05	0.00124	CbGpPWpGaD
Rivastigmine—ACHE—Neuronal System—PRKCG—Alzheimer's disease	2.63e-05	0.00123	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—CA4—Alzheimer's disease	2.57e-05	0.0012	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—ATP5A1—Alzheimer's disease	2.57e-05	0.0012	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of proteins—HSPD1—Alzheimer's disease	2.57e-05	0.0012	CbGpPWpGaD
Rivastigmine—ACHE—Transmission across Chemical Synapses—CREB1—Alzheimer's disease	2.55e-05	0.00119	CbGpPWpGaD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—IGF1—Alzheimer's disease	2.54e-05	0.00119	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of lipids and lipoproteins—A2M—Alzheimer's disease	2.51e-05	0.00118	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of proteins—MME—Alzheimer's disease	2.46e-05	0.00115	CbGpPWpGaD
Rivastigmine—CYP2D6—Biological oxidations—PTGS1—Alzheimer's disease	2.45e-05	0.00115	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—PLD3—Alzheimer's disease	2.45e-05	0.00115	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of lipids and lipoproteins—INPP5D—Alzheimer's disease	2.42e-05	0.00113	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—GAPDHS—Alzheimer's disease	2.42e-05	0.00113	CbGpPWpGaD
Rivastigmine—BCHE—Neuronal System—PRKCG—Alzheimer's disease	2.35e-05	0.0011	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—HSD17B10—Alzheimer's disease	2.35e-05	0.0011	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of lipids and lipoproteins—PTGS1—Alzheimer's disease	2.29e-05	0.00108	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—ATP5A1—Alzheimer's disease	2.29e-05	0.00107	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of proteins—HSPD1—Alzheimer's disease	2.29e-05	0.00107	CbGpPWpGaD
Rivastigmine—ACHE—Neuronal System—CALM1—Alzheimer's disease	2.28e-05	0.00107	CbGpPWpGaD
Rivastigmine—BCHE—Transmission across Chemical Synapses—CREB1—Alzheimer's disease	2.27e-05	0.00106	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—CYP46A1—Alzheimer's disease	2.26e-05	0.00106	CbGpPWpGaD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—BCL2—Alzheimer's disease	2.22e-05	0.00104	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—PLD3—Alzheimer's disease	2.18e-05	0.00102	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of lipids and lipoproteins—ACHE—Alzheimer's disease	2.18e-05	0.00102	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—ND1—Alzheimer's disease	2.18e-05	0.00102	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of proteins—EIF2S1—Alzheimer's disease	2.17e-05	0.00102	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of lipids and lipoproteins—INPP5D—Alzheimer's disease	2.16e-05	0.00101	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of lipids and lipoproteins—BCHE—Alzheimer's disease	2.13e-05	0.001	CbGpPWpGaD
Rivastigmine—CYP3A4—Biological oxidations—MAOB—Alzheimer's disease	2.11e-05	0.000991	CbGpPWpGaD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—PTGS2—Alzheimer's disease	2.11e-05	0.000987	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—HSD17B10—Alzheimer's disease	2.09e-05	0.000982	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of lipids and lipoproteins—PTGS1—Alzheimer's disease	2.05e-05	0.00096	CbGpPWpGaD
Rivastigmine—BCHE—Neuronal System—CALM1—Alzheimer's disease	2.03e-05	0.000952	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—CYP46A1—Alzheimer's disease	2.02e-05	0.000945	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of proteins—CTSD—Alzheimer's disease	2e-05	0.000939	CbGpPWpGaD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—CASP3—Alzheimer's disease	1.96e-05	0.000916	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	1.95e-05	0.000915	CbGpPWpGaD
Rivastigmine—ACHE—Neuronal System—CREB1—Alzheimer's disease	1.95e-05	0.000914	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—ND1—Alzheimer's disease	1.95e-05	0.000913	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of proteins—EIF2S1—Alzheimer's disease	1.93e-05	0.000907	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of proteins—ACHE—Alzheimer's disease	1.89e-05	0.000885	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of proteins—GSK3A—Alzheimer's disease	1.88e-05	0.000879	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of proteins—BCHE—Alzheimer's disease	1.84e-05	0.000864	CbGpPWpGaD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—MAPK8—Alzheimer's disease	1.8e-05	0.000842	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of proteins—CTSD—Alzheimer's disease	1.79e-05	0.000838	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of proteins—ACE—Alzheimer's disease	1.79e-05	0.000837	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	1.74e-05	0.000816	CbGpPWpGaD
Rivastigmine—BCHE—Neuronal System—CREB1—Alzheimer's disease	1.74e-05	0.000815	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	1.68e-05	0.000788	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of proteins—GSK3A—Alzheimer's disease	1.67e-05	0.000784	CbGpPWpGaD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—VEGFA—Alzheimer's disease	1.66e-05	0.000778	CbGpPWpGaD
Rivastigmine—CYP3A4—Biological oxidations—PTGS1—Alzheimer's disease	1.6e-05	0.000751	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of proteins—ACE—Alzheimer's disease	1.59e-05	0.000747	CbGpPWpGaD
Rivastigmine—CYP3A4—Biological oxidations—CYP2D6—Alzheimer's disease	1.57e-05	0.000737	CbGpPWpGaD
Rivastigmine—CYP3A4—Metapathway biotransformation—CYP2D6—Alzheimer's disease	1.55e-05	0.000727	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	1.53e-05	0.000718	CbGpPWpGaD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—TGFB1—Alzheimer's disease	1.52e-05	0.000714	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	1.5e-05	0.000703	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of proteins—IGF2—Alzheimer's disease	1.43e-05	0.000669	CbGpPWpGaD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—TNF—Alzheimer's disease	1.42e-05	0.000666	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—TPI1—Alzheimer's disease	1.41e-05	0.000659	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—CHAT—Alzheimer's disease	1.41e-05	0.000659	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—DHCR24—Alzheimer's disease	1.39e-05	0.000651	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	1.37e-05	0.00064	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—MAOB—Alzheimer's disease	1.35e-05	0.000632	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—GAPDH—Alzheimer's disease	1.3e-05	0.000608	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	1.28e-05	0.000602	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of proteins—IGF2—Alzheimer's disease	1.27e-05	0.000597	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	1.27e-05	0.000596	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—TPI1—Alzheimer's disease	1.25e-05	0.000588	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—CHAT—Alzheimer's disease	1.25e-05	0.000588	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—A2M—Alzheimer's disease	1.25e-05	0.000588	CbGpPWpGaD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—TP53—Alzheimer's disease	1.25e-05	0.000588	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—MAOB—Alzheimer's disease	1.2e-05	0.000564	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—CA4—Alzheimer's disease	1.18e-05	0.000554	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—GAPDH—Alzheimer's disease	1.16e-05	0.000543	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	1.15e-05	0.000537	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	1.13e-05	0.000532	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—A2M—Alzheimer's disease	1.12e-05	0.000524	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	1.12e-05	0.000524	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—GAPDHS—Alzheimer's disease	1.11e-05	0.000521	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of proteins—LEP—Alzheimer's disease	1.11e-05	0.00052	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—INPP5D—Alzheimer's disease	1.08e-05	0.000505	CbGpPWpGaD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—AKT1—Alzheimer's disease	1.06e-05	0.000496	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—ATP5A1—Alzheimer's disease	1.05e-05	0.000494	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of proteins—F2—Alzheimer's disease	1.05e-05	0.00049	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—PTGS1—Alzheimer's disease	1.02e-05	0.000479	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—ENO1—Alzheimer's disease	1.02e-05	0.000479	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—PLD3—Alzheimer's disease	1e-05	0.000471	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—CYP2D6—Alzheimer's disease	1e-05	0.00047	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	9.97e-06	0.000467	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of proteins—LEP—Alzheimer's disease	9.89e-06	0.000464	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—ACHE—Alzheimer's disease	9.73e-06	0.000456	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—HSD17B10—Alzheimer's disease	9.63e-06	0.000451	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—INPP5D—Alzheimer's disease	9.62e-06	0.000451	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—BCHE—Alzheimer's disease	9.5e-06	0.000445	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of proteins—INS—Alzheimer's disease	9.47e-06	0.000444	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of proteins—F2—Alzheimer's disease	9.33e-06	0.000437	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of proteins—CCL2—Alzheimer's disease	9.32e-06	0.000437	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—CYP46A1—Alzheimer's disease	9.27e-06	0.000435	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of proteins—IGF1—Alzheimer's disease	9.16e-06	0.00043	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—PTGS1—Alzheimer's disease	9.12e-06	0.000427	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—ENO1—Alzheimer's disease	9.12e-06	0.000427	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—DHCR24—Alzheimer's disease	9.08e-06	0.000426	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—PLCB1—Alzheimer's disease	8.97e-06	0.00042	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—ND1—Alzheimer's disease	8.95e-06	0.00042	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—CYP2D6—Alzheimer's disease	8.94e-06	0.000419	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	8.79e-06	0.000412	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—ABCA1—Alzheimer's disease	8.69e-06	0.000407	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of proteins—INS—Alzheimer's disease	8.45e-06	0.000396	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of proteins—CCL2—Alzheimer's disease	8.32e-06	0.00039	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of proteins—IGF1—Alzheimer's disease	8.18e-06	0.000383	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—PLCB1—Alzheimer's disease	8e-06	0.000375	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	7.85e-06	0.000368	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—ABCA1—Alzheimer's disease	7.75e-06	0.000363	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—CA4—Alzheimer's disease	7.72e-06	0.000362	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—PPARGC1A—Alzheimer's disease	7.49e-06	0.000351	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—HMOX1—Alzheimer's disease	7.46e-06	0.000349	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—GAPDHS—Alzheimer's disease	7.26e-06	0.00034	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—ATP5A1—Alzheimer's disease	6.88e-06	0.000323	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—LPL—Alzheimer's disease	6.82e-06	0.00032	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—PPARGC1A—Alzheimer's disease	6.68e-06	0.000313	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—HMOX1—Alzheimer's disease	6.65e-06	0.000312	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—PLD3—Alzheimer's disease	6.57e-06	0.000308	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—HSD17B10—Alzheimer's disease	6.3e-06	0.000295	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—MTHFR—Alzheimer's disease	6.14e-06	0.000288	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—LPL—Alzheimer's disease	6.08e-06	0.000285	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—CYP46A1—Alzheimer's disease	6.06e-06	0.000284	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—ND1—Alzheimer's disease	5.85e-06	0.000274	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—TPI1—Alzheimer's disease	5.77e-06	0.00027	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—CHAT—Alzheimer's disease	5.77e-06	0.00027	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—CALM1—Alzheimer's disease	5.74e-06	0.000269	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—APOE—Alzheimer's disease	5.72e-06	0.000268	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—CAV1—Alzheimer's disease	5.66e-06	0.000265	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—MAOB—Alzheimer's disease	5.53e-06	0.000259	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—MTHFR—Alzheimer's disease	5.48e-06	0.000257	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—GAPDH—Alzheimer's disease	5.32e-06	0.00025	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—A2M—Alzheimer's disease	5.14e-06	0.000241	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—CALM1—Alzheimer's disease	5.12e-06	0.00024	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—APOE—Alzheimer's disease	5.1e-06	0.000239	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—CAV1—Alzheimer's disease	5.05e-06	0.000237	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—PPARG—Alzheimer's disease	4.98e-06	0.000233	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—INS—Alzheimer's disease	4.88e-06	0.000229	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—ACHE—Alzheimer's disease	4.47e-06	0.00021	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—PPARG—Alzheimer's disease	4.44e-06	0.000208	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—INPP5D—Alzheimer's disease	4.42e-06	0.000207	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—INS—Alzheimer's disease	4.36e-06	0.000204	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—NOS3—Alzheimer's disease	4.28e-06	0.000201	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—ENO1—Alzheimer's disease	4.19e-06	0.000196	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—PTGS1—Alzheimer's disease	4.19e-06	0.000196	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—PTGS2—Alzheimer's disease	3.92e-06	0.000184	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—BCHE—Alzheimer's disease	3.9e-06	0.000183	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—NOS3—Alzheimer's disease	3.82e-06	0.000179	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—CHAT—Alzheimer's disease	3.77e-06	0.000177	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—TPI1—Alzheimer's disease	3.77e-06	0.000177	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—PLCB1—Alzheimer's disease	3.68e-06	0.000172	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—MAOB—Alzheimer's disease	3.62e-06	0.00017	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—ABCA1—Alzheimer's disease	3.56e-06	0.000167	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—PTGS2—Alzheimer's disease	3.49e-06	0.000164	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—GAPDH—Alzheimer's disease	3.48e-06	0.000163	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—A2M—Alzheimer's disease	3.36e-06	0.000158	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—PPARGC1A—Alzheimer's disease	3.07e-06	0.000144	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—HMOX1—Alzheimer's disease	3.06e-06	0.000143	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—ACHE—Alzheimer's disease	2.93e-06	0.000137	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—INPP5D—Alzheimer's disease	2.89e-06	0.000136	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—LPL—Alzheimer's disease	2.8e-06	0.000131	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—ENO1—Alzheimer's disease	2.74e-06	0.000128	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—PTGS1—Alzheimer's disease	2.74e-06	0.000128	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—CYP2D6—Alzheimer's disease	2.69e-06	0.000126	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—BCHE—Alzheimer's disease	2.55e-06	0.000119	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—MTHFR—Alzheimer's disease	2.52e-06	0.000118	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—PLCB1—Alzheimer's disease	2.4e-06	0.000113	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—CALM1—Alzheimer's disease	2.35e-06	0.00011	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—APOE—Alzheimer's disease	2.34e-06	0.00011	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—ABCA1—Alzheimer's disease	2.33e-06	0.000109	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—CAV1—Alzheimer's disease	2.32e-06	0.000109	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—PPARG—Alzheimer's disease	2.04e-06	9.57e-05	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—PPARGC1A—Alzheimer's disease	2.01e-06	9.41e-05	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—INS—Alzheimer's disease	2e-06	9.39e-05	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—HMOX1—Alzheimer's disease	2e-06	9.37e-05	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—AKT1—Alzheimer's disease	1.97e-06	9.23e-05	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—LPL—Alzheimer's disease	1.83e-06	8.57e-05	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—NOS3—Alzheimer's disease	1.76e-06	8.23e-05	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—AKT1—Alzheimer's disease	1.76e-06	8.23e-05	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—MTHFR—Alzheimer's disease	1.65e-06	7.72e-05	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—PTGS2—Alzheimer's disease	1.61e-06	7.53e-05	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—CALM1—Alzheimer's disease	1.54e-06	7.21e-05	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—APOE—Alzheimer's disease	1.53e-06	7.18e-05	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—CAV1—Alzheimer's disease	1.52e-06	7.12e-05	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—PPARG—Alzheimer's disease	1.34e-06	6.26e-05	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—INS—Alzheimer's disease	1.31e-06	6.14e-05	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—NOS3—Alzheimer's disease	1.15e-06	5.38e-05	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—PTGS2—Alzheimer's disease	1.05e-06	4.92e-05	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—AKT1—Alzheimer's disease	8.07e-07	3.78e-05	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—AKT1—Alzheimer's disease	5.28e-07	2.47e-05	CbGpPWpGaD
